EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
2.150
-0.070 (-3.15%)
At close: May 12, 2025, 4:00 PM
2.150
0.00 (0.00%)
After-hours: May 12, 2025, 4:00 PM EDT
EDAP TMS Revenue
In the year 2024, EDAP TMS had annual revenue of 64.12M EUR with 6.11% growth. EDAP TMS had revenue of 20.32M in the quarter ending December 31, 2024, with 3.59% growth.
Revenue (ttm)
64.12M EUR
Revenue Growth
+6.11%
P/S Ratio
1.21
Revenue / Employee
206,823 EUR
Employees
310
Market Cap
80.39M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64.12M | 3.69M | 6.11% |
Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
EDAP News
- 11 days ago - EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025 - GlobeNewsWire
- 13 days ago - EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 18 days ago - EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 20 days ago - EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 6 weeks ago - EDAP TMS S.A. (EDAP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results - GlobeNewsWire
- 2 months ago - EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewsWire
- 2 months ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire